Specific interaction between tetrandrine and Quillaja saponins in promoting permeabilization of plasma membrane in human leukemic HL-60 cells

Biochimica et Biophysica Acta - Biomembranes

Volumn 1325, Issue 2, 1997, Pages 318-328

  Leung, Yuk Man ^a,b   Ou, Yi Jun ^b   Kwan, Chiu Yin ^b   Loh, Tatt Tuck ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

HL 60 cell; Mn2+; Ni2+; Saponin; Tetrandrine

Indexed keywords

DIGITONIN; DILTIAZEM; FILIPIN; IONOMYCIN; SAPONIN; TETRANDRINE; VERAPAMIL;

ARTICLE; CELL STRAIN HL 60; CHANNEL GATING; CONTROLLED STUDY; FLUORESCENCE; HUMAN; HUMAN CELL; MEMBRANE FLUIDITY; MEMBRANE PERMEABILITY; PRIORITY JOURNAL;

ALKALOIDS; BENZYLISOQUINOLINES; CALCIUM; CALCIUM CHANNEL BLOCKERS; CELL MEMBRANE PERMEABILITY; DRUG INTERACTIONS; FURA-2; HL-60 CELLS; HUMANS; ION CHANNELS; MANGANESE; MEMBRANE FLUIDITY; NICKEL; SAPONINS;

PANAX GINSENG; QUILLAJA; QUILLAJA SAPONARIA; SAPONARIA;

EID: 0030895024     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2736(97)00002-3     Document Type: Article

References (46)

1. Gao, Y., Chang, M.Y., Mao, H.Y., Chao, H.Y. and Chen, D.H. (1965) J. Clin. Intern. Med. 13, 504-507.
2. Qian, J.Q., Thoolen, M.J.M.C., Van Meel, J.C.A., Timmermans, P.B.M.W.M. and Van Zwieten, P.A. (1983) Pharmacology 26, 187-197.
3. Li, Q.L., Xu, Y.H., Zhon, Z.H., Chen, X.W., Huang, X.G., Chen, S.L. and Zhan, C.X. (1981) Chin. J. Tuberc. Resp. Dis. 4, 321-328.
4. Yu, X.F., Zou, C.G. and Lih, M.B. (1983) Ecotoxicol. Environ. Safety 7, 306-312.
5. Wang, G. and Lemos, J.R. (1995) Life Sci. 56, 295-306.
6. King, V.F., Garcia, M.L., Himmel, D., Reuben, J.P., Lam Y.K.T., Pan, J.X., Han, G.Q. and Kaczorowski G.J. (1988) J. Biol. Chem. 263, 2238-2244.
7. Liu, Q.Y., Karpinski, E. and Pang, P.K.T. (1992) J. Cardiovasc. Pharmacol. 20, 513-519.
8. Rossier, M.F., Python, C.P., Capponi, A.M., Schlegel, W., Kwan, C.Y. and Vallotton, M.B. (1993) Endocrinology 132, 1035-1043.
9. Wang, G. and Lemos, J.R. (1992) Pflugers Arch. 421, 558-565.
10. Kwan, C.Y., Deng, H.W. and Guan, Y.Y. (1992) Acta Pharmacol. Sin. 13, 385-390.
11. Liu, Q.Y., Li, B., Gang, J.M., Karpinski, E. and Pang, P.K.T. (1995) J. Pharmacol. Exp. Ther. 273, 32-39.
12. Leung, Y.M., Kwan, C.Y. and Loh, T.T. (1994) Br. J. Pharmacol. 113, 767-774.
13. Takemura, H. Kwan, C.Y. and Ohshika, H. (1995) Res. Commun. Mol. Pathol. Pharmacol. 90, 59-68.
14. Chen, N.H., Wang, Y.L. and Ding, J.H. (1991) Acta Pharmacol. Sin. 12, 488-493.
15. Ioannoni, B., Chalmers, A.H., Seow, W.K., McCormack, J.G. and Thong, Y.H. (1989) Int. Arch. Allergy Appl. Immunol. 89, 349-354.
16. Demaurex, N., Lew, D.P. and Krause, K.H. (1992) J. Biol. Chem. 267, 2318-2324.
17. Berridge, M.J. (1995) Biochem. J. 312, 1-11.
18. Leung, Y.M., Berdik, M., Kwan, C.Y. and Loh, T.T. (1996) Clin. Exp. Pharmacol. Physiol. 23, 653-659.
19. Shany, S., Bernheimer, A.W. and Grushoff, P.S. (1974) Mol. Cell Biochem. 3, 179-186.
20. Bridgman, P.C. and Nakajima, Y. (1981) Proc. Natl. Acad. Sci. USA 78, 1278-1282.
21. Leung, Y.M., Kwan, C.Y. and Loh, T.T. (1996) Biochem. Pharmacol. 51, 605-612.
22. Merritt, J.E., Jacob, R. and Hallam, T.J. (1989) J. Biol. Chem. 264, 1522-1527.
23. Stout, M.A. and Diecke, F.P.J. (1983) J. Pharmacol. Exp. Ther. 225, 102-111.
24. Kwan, C.Y. (1985) Biochim. Biophy. Acta 819, 148-152.
25. Kwan, C.Y., Gaspar, V. and Guan, Y.Y. (1990) Biochem. Arch. 6, 367-373.
26. Chapman, D. (1983) In Membrane Fluidity in Biology, Vol 2, General Principles (Aloia, R.C., eds.), pp. 5-42, Academic Press, New York.
27. Lee, N.M. and Becker, C.E. (1987) In Basic and Clinical Pharmacology (Katzung, B.G., eds), pp. 254-261, Prentice-Hall International.
28. Ma, L.J., Yin, Z.Z. and Liu, G.Z. (1991) Chin. J. Pharmacol. Toxicol. 5, 41-43.
29. Hashizume, T., Yamaguchi, H., Sato, T. and Fujii, T. (1991) Biochem. Pharmacol. 41, 419-423.
30. Li, B.Y., Zhang, Y.C. and Li, W.H. (1993) Acta Pharmacol. Sin. 13, 412-416.
31. Iino, M. (1990) J. Gen. Physiol. 95, 1103-1122.
32. Guse, A.H., Roth, E. and Emmrich, F. (1993) Biochem. J. 291, 447-451.
33. Servant, M., Guillemette, G. and Morisset, J. (1995) Biochem. J. 305, 103-110.
34. Kwan, C.Y. and Wang, Z.L. (1993) Eur. J. Pharmacol. 238, 431-434.
35. Rao, A.V. and Sung, M.K. (1995) J. Nutr. 125, 717S-724S.
36. Kersten, G.F.A. and Crommelin, D.J.A. (1995) Biochim. Biophy. Acta 1241, 117-138.
37. The Merck Index, 10th edition (1983) (Windholz, M. eds), pp. 458, Merck and Co., Rahway, New Jersey.
38. Mason, R.P. and Trumbore, M.W. (1996) Biochem. Pharmacol. 51, 653-660.
39. Teh, B.S., Seow, W.K., Li, S.Y. and Thong, Y.H. (1990) Int. J. Immunopharmacol. 12, 321-326.
40. Seow, W.K., Ferrante, A., Summors, A. and Thong, Y.H. (1992) Life Sci. 50, PL53-58.
41. Whitehouse, M.W., Fairlie, D.P. and Thong, Y.H. (1994) Agents Actions 42, 123-127.
42. Felix, J.P., King, V.F., Shevell, J.L., Garcia, M.L., Kaczorowski, G.J., Bick, I.R.C. and Slaughter, R.S. (1992) Biochemistry 31, 11793-11800.
43. Chavali, S.R., Francis, T. and Campbell, J.B. (1987) Int. J. Immunopharmacol. 9, 675-683.
44. Morein, B., Sundquist, B., Hoglund, S., Dalsgaard, K. and Osterhaus, A. (1984) Nature 308, 457-460.
45. Stott, E.J., Chan, W.L., Mills, K.H.G., Page, M., Taffs, F., Cranage, M., Greenaway, P. and Kitchin, P. (1990) Lancet 336, 1538-1541.
46. Gupta, R.K., Relyveld, E.H., Lindblad, E.B., Bizzini, B., Ben-Efraim, S. and Gupta, C.K. (1993) Vaccine 11, 293-306.